⚖
UPC-Intel
European patent decisions • UPC · EPO · national courts
Search
How It Works
Docs & MCP
Pricing
Sign In →
PATENT
EP2981255
Therapeutic uses of empagliflozin
Court proceedings (1)
🏛️ EPO Munich
EPO T 0251/25
EPO Board of Appeal 3.3.04 (Munich)
2026-06-29
Boehringer Ingelheim International GmbH v. TEVA PHARMACEUTICAL INDUSTRIES, LTD., ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. +9
opposition appeal
EP2981255
1 document